New York, Jan 28, 2026, 12:03 EST — Regular session
- Walmart shares were little changed at $116.87 in midday trade
- Retailer lifts pay for pharmacy technicians as it expands healthcare services
- Investors eye the Fed later Wednesday and Walmart’s Feb. 19 results
Walmart Inc (WMT.O) shares were little changed on Wednesday, down about 0.1% at $116.87, after the retailer raised pay for thousands of pharmacy technicians as it leans harder into healthcare. Walmart said it elevated 3,000 roles to pharmacy operations team lead positions, lifting average pay to $28 an hour from $22, while expanding technician pay ranges up to $40.50 an hour and team lead pay potential up to $42 an hour plus bonus, depending on location. “This investment is really about supporting the pharmacy teams who show up for their communities every day,” said Kevin Host, Walmart’s senior vice president of pharmacy. (Walmart News & Leadership)
The move lands as big drugstore chains pull back. CVS and Walgreens have cut hours and closed pharmacies across the U.S., while Walmart is trying to widen what its stores can do for patients beyond filling prescriptions. “With pharmacy care, you don’t need an appointment,” Host told Axios, as Walmart shifts more work into automated “central fill” hubs that can fill prescriptions for multiple stores and plans to open two more such facilities this year. (Axios)
It also comes with nerves showing up in the consumer data. The Conference Board’s consumer confidence index fell 9.7 points in January to 84.5, the lowest level since May 2014, amid worries about high prices and a softening view of the labor market. “We’d be surprised if its recent deterioration proves to be an entirely false signal,” said Oliver Allen, senior U.S. economist at Pantheon Macroeconomics. (Reuters)
Competition is sharpening too. Amazon has been expanding same-day prescription delivery to more U.S. cities and this month began offering Novo Nordisk’s Wegovy through insurance plans, with cash prices starting at about $149 a month, raising the stakes for speed and convenience in pharmacy. Walmart has been rolling out digital offerings tied to its stores, including Better Care Services, access to Eli Lilly’s LillyDirect program and expanded pharmacy delivery. (Reuters)
The broader tape has been supportive, even if Walmart’s stock barely budged. The S&P 500 pushed through 7,000 on Wednesday as investors positioned for the Federal Reserve decision and a wave of big tech earnings. The Fed is widely expected to hold its benchmark overnight rate steady at 3.5%–3.75%, with traders parsing the statement and Chair Jerome Powell’s remarks for the next turn. (Reuters)
For Walmart investors, the question is less about a single pay change and more about what it signals. Raising wages can help retention and staffing in pharmacies — a customer-facing business where wait times and service matter — but it also adds to costs at a time when retailers are watching expenses closely.
Next up is earnings. Walmart has scheduled its fiscal fourth-quarter results for Feb. 19, with materials expected around 6 a.m. Central time and a conference call at 7 a.m. CT, according to the company’s events calendar. (Walmart News & Leadership)
But higher wages are not a free bet. Pharmacy profits can be squeezed by reimbursement pressure and discounting, and rivals are pushing hard on delivery and weight-loss drug access. If the consumer slowdown hinted at in confidence surveys spills into spending, investors may press for more proof that new healthcare services drive traffic and margin, not just payroll.
Traders will watch the Fed later Wednesday for any shift in the rate outlook, then turn to Walmart’s Feb. 19 update for details on healthcare growth, pharmacy service levels and the cost of keeping stores staffed.
